Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights ...Middle East

PR Newswire - News
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Announced CT-0525 as lead product candidate for anti-HER2 program; initial data expected by year-end 2024 Presented preclinical proof of concept data in liver fibrosis at ASGCT; expects to nominate a development candidate in the first quarter of 2025 Presented Regimen Level 1 data from...

Hence then, the article about carisma therapeutics reports first quarter 2024 financial results and recent business highlights was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights )

Apple Storegoogle play

Last updated :

Also on site :